A meta-analysis of clinical trials comparing milnacipran, a serotonin–norepinephrine reuptake inhibitor, with a selective serotonin reuptake inhibitor for the treatment of major depressive disorder

Depressive Disorder ◽

Reuptake Inhibitor ◽

Serotonin Reuptake ◽

Meta Analysis ◽

Major Depressive ◽

A meta-analysis of clinical trials comparing reboxetine, a norepinephrine reuptake inhibitor, with selective serotonin reuptake inhibitors for the treatment of major depressive disorder

European Neuropsychopharmacology ◽

10.1016/j.euroneuro.2007.07.005 ◽

2008 ◽

Vol 18 (2) ◽

pp. 122-127 ◽

Cited By ~ 42

Author(s):

George I. Papakostas ◽

J. Craig Nelson ◽

Siegfried Kasper ◽

Hans-Jürgen Möller

Keyword(s):

Clinical Trials ◽

Depressive Disorder ◽

Reuptake Inhibitor ◽

Serotonin Reuptake ◽

Selective Serotonin Reuptake Inhibitors ◽

Meta Analysis ◽

Major Depressive ◽

Duloxetine: A Dual Serotonin-Norepinephrine Reuptake Inhibitor for Treatment of Major Depressive Disorder

Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ◽

10.1592/phco.25.3.396.61600 ◽

2005 ◽

Vol 25 (3) ◽

pp. 396-410 ◽

Cited By ~ 23

Author(s):

Jennifer L. Kirwin ◽

Jessica L. Gören

Keyword(s):

Depressive Disorder ◽

Reuptake Inhibitor ◽

Major Depressive ◽

Desvenlafaxine: A new serotonin-norepinephrine reuptake inhibitor for the treatment of adults with major depressive disorder

Clinical Therapeutics ◽

10.1016/j.clinthera.2009.07.012 ◽

2009 ◽

Vol 31 ◽

pp. 1374-1404 ◽

Cited By ~ 25

Author(s):

Richard Perry ◽

Manouchkathe Cassagnol

Keyword(s):

Depressive Disorder ◽

Reuptake Inhibitor ◽

Major Depressive ◽

Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin–norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials

Australian & New Zealand Journal of Psychiatry ◽

10.1177/0004867414525837 ◽

2014 ◽

Vol 48 (7) ◽

pp. 663-671 ◽

Cited By ~ 18

Author(s):

Kai-Lin Huang ◽

Wan-Chen Lu ◽

Ying-Yue Wang ◽

Gwo-Chi Hu ◽

Chien-Hung Lu ◽

...

Keyword(s):

Clinical Trials ◽

Depressive Disorder ◽

Serotonin Reuptake ◽

Selective Serotonin Reuptake Inhibitors ◽

Randomized Clinical Trials ◽

Meta Analysis ◽

Serotonin Reuptake Inhibitors ◽

Major Depressive ◽

Randomized controlled trials of serotonin-norepinephrine reuptake inhibitor in treating major depressive disorder in children and adolescents: a meta-analysis of efficacy and acceptability

Brazilian Journal of Medical and Biological Research ◽

10.1590/1414-431x20164806 ◽

2016 ◽

Vol 49 (6) ◽

Cited By ~ 11

Author(s):

Y. Xu ◽

S.J. Bai ◽

X.H. Lan ◽

B. Qin ◽

T. Huang ◽

...

Keyword(s):

Depressive Disorder ◽

Randomized Controlled Trials ◽

Meta Analysis ◽

Controlled Trials ◽

Major Depressive ◽

Randomized Controlled ◽

Is a serotonin–norepinephrine reuptake inhibitor superior to an SSRI in the treatment of major depressive disorder in adults?

Evidence-Based Practice ◽

10.1097/ebp.0000000000001375 ◽

2021 ◽

Vol Publish Ahead of Print ◽

Author(s):

Kate Geschwind ◽

David V. Power

Keyword(s):

Depressive Disorder ◽

Reuptake Inhibitor ◽

Major Depressive ◽

Desvenlafaxine for major depressive disorder: incremental clinical benefits from a second-generation serotonin–norepinephrine reuptake inhibitor

Expert Opinion on Drug Metabolism & Toxicology ◽

10.1517/17425255.2010.535810 ◽

2010 ◽

Vol 6 (12) ◽

pp. 1565-1574 ◽

Cited By ~ 8

Author(s):

Alice I Nichols ◽

Karen A Tourian ◽

Susanna Y Tse ◽

Jeffrey Paul

Keyword(s):

Depressive Disorder ◽

Reuptake Inhibitor ◽

Second Generation ◽

Major Depressive ◽

Clinical Benefits ◽

Evaluation of efficacy and clinical benefit of agomelatine in patients with major depressive disorder compared to serotonin-norepinephrine reuptake inhibitor (SNRI)

http://isrctn.org/> ◽

10.1186/isrctn96725312 ◽

2012 ◽

Author(s):

Christine Marey

Keyword(s):

Depressive Disorder ◽

Reuptake Inhibitor ◽

Clinical Benefit ◽

Major Depressive ◽

Efficacy Outcomes From 3 Clinical Trials of Edivoxetine as Adjunctive Treatment for Patients With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor Treatment

The Journal of Clinical Psychiatry ◽

10.4088/jcp.14m09619 ◽

2016 ◽

Vol 77 (05) ◽

pp. 635-642 ◽

Cited By ~ 5

Author(s):

Susan G. Ball ◽

Margaret B. Ferguson ◽

James M. Martinez ◽

Beth A. Pangallo ◽

E. Serap Monkul Nery ◽

...

Keyword(s):

Clinical Trials ◽

Depressive Disorder ◽

Selective Serotonin Reuptake Inhibitor ◽

Reuptake Inhibitor ◽

Serotonin Reuptake ◽

Selective Serotonin ◽

Adjunctive Treatment ◽

Major Depressive ◽

Inhibitor Treatment

Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of anxiety symptoms in major depressive disorder: A meta-analysis of individual patient data from 10 double-blind, randomized clinical trials

Journal of Psychiatric Research ◽

10.1016/j.jpsychires.2007.05.012 ◽

2008 ◽

Vol 42 (2) ◽

pp. 134-140 ◽

Cited By ~ 19

Author(s):

George I. Papakostas ◽

Madhukar H. Trivedi ◽

Jonathan E. Alpert ◽

Cheryl A. Seifert ◽

Alok Krishen ◽

...

Keyword(s):

Clinical Trials ◽

Depressive Disorder ◽

Serotonin Reuptake ◽

Selective Serotonin Reuptake Inhibitors ◽

Randomized Clinical Trials ◽

Individual Patient Data ◽

Meta Analysis ◽

Major Depressive ◽

Double Blind